Published in J Exp Med on July 01, 1973
The mitogenic, immunogenic and tolerogenic properties of dextrans and levans. Lack of correlation according to differences of molecular structure and size. Immunology (1977) 0.91
Suppression of murine lymphocyte mitogen responses by exopolysaccharide from Capnocytophaga ochracea. Infect Immun (1983) 0.88
Modulation of the immune response to sheep erythrocytes by lipid-free glycerol teichoic acid. Infect Immun (1979) 0.85
Adjuvant effects of diethylaminoethyl-dextran. Infect Immun (1976) 0.80
Immunosuppression of anti-sheep erythrocyte responses by glycerol teichoic acid immune complexes. Infect Immun (1980) 0.78
Dextran induces changes in immunological responses to unrelated antigenic and haptenic stimuli. Immunology (1973) 0.78
Dextran-triggered T cells heighten T- and B-cell reactions to mitogens. Immunology (1976) 0.77
Polymer therapeutics in surgery: the next frontier. J Interdiscip Nanomed (2016) 0.75
Dental caries and periodontal disease. J R Soc Med (1978) 0.75
Plaque Formation in Agar by Single Antibody-Producing Cells. Science (1963) 10.20
Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency. Nature (1965) 6.84
Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol (1971) 6.43
Tuberculin-induced mitosis in peripheral blood leucocytes. Lancet (1963) 6.22
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
STUDIES ON GLOBULIN AND ANTIBODY PRODUCTION IN MICE THYMECTOMIZED AT BIRTH. Immunology (1964) 5.05
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
PPD tuberculin--a B-cell mitogen. Nat New Biol (1972) 4.70
Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide. Cell Immunol (1971) 4.69
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Detection of cells producing 7S antibodies by the plaque technique. Nature (1965) 4.64
Functional heterogeneity of murine lymphoid cells. I. Responsiveness to and surface binding of concanavalin A and phytohemagglutinin. J Immunol (1972) 3.96
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity. J Exp Med (1972) 3.80
Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature (1971) 3.30
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide. Cell Immunol (1971) 2.42
Lymphocyte activation. II. discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera. Clin Exp Immunol (1972) 2.37
A role of macrophages in the stimulation of immune responses by adjuvants. J Immunol (1969) 2.06
Purified protein derivative of tuberculin induces immunoglobulin production in normal mouse spleen cells. J Exp Med (1973) 1.98
Studies on the adjuvant action of bacterial endotoxins on antibody formation. I. Time limitation of enhancing effect and restoration of antibody formation in x-irradiated rabbits. J Immunol (1959) 1.94
Cell transformations and mitoses produced in vitro by tuberculin purified protein derivative in human blood cells. Am Rev Respir Dis (1963) 1.92
Enhancing effect of bacterial endotoxins on bone marrow cells in the immune response to SRBC. J Immunol (1972) 1.69
The role of T cells and adjuvant in the immune response of mice to foreign erythrocytes. Eur J Immunol (1972) 1.48
Myelosclerosis: an autoimmune disease. Lancet (1963) 1.44
Evidence for thymic dependence of PHA-reactive cells in spleen and lymph nodes and independence in bone marrow. J Immunol (1971) 1.25
Selective stimulation of IgM synthesis in mouse B lymphocytes by pokeweed mitogen. Nat New Biol (1972) 1.12
The immune response in mice to the haptenic determinant DNP coupled to a thymus-independent carrier (levan). J Immunol (1972) 1.07
Thymus-derived cell (T cell) activation by heterologous antigens as a replacement of specific immune T cells in the transfer of the secondary response to sheep erythrocytes. J Exp Med (1972) 1.05
Effects of anti-lymphocyte, anti-macrophage and anti-thymocyte serum IgG on the immune response. Int Arch Allergy Appl Immunol (1971) 1.04
Enhancement by the adjuvant, endotoxin, of an immune response induced in vitro. Immunology (1970) 1.02
Increased plaque-forming cell response to pneumococcal polysaccharide type 3-coated sheep erythrocytes after priming with erythrocytes but not with polysaccharide. Cell Immunol (1972) 0.88
B cell activation in vivo by nonantigen-specific interaction with T cells. Frequency of immune responses increased by immunization with two antigens. J Exp Med (1972) 0.88
Increased priming for the secondary response in mice to sheep erythrocytes by bacterial endotoxins. Int Arch Allergy Appl Immunol (1970) 0.82
Response of mice to rabbit Fab' 2 and Fab'. Thymus independence of IgM response and thymus dependence of IgG response. Immunology (1972) 0.82
Stimulation of humoral antibody formation by polyanions. IV. The effects of dextran sulfate on the kinetics of secondary immune response in mice. Eur J Immunol (1971) 0.82
In vitro detection of spontaneously occurring delayed-type iso-hypersensitivity. Immunology (1971) 0.78
Isogeneic lymphocyte interaction: recognition of self antigens by cells of the neonatal thymus. Proc Natl Acad Sci U S A (1970) 1.78
Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature (1966) 1.68
Influence of thymosin on cell-mediated and humoral immune responses in normal and in immunologically deficient mice. J Immunol (1970) 1.62
Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization. Dig Dis Sci (1979) 1.60
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology (2002) 1.58
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab (1992) 1.51
Splenic T-killer cells can be generated by allogeneic thymic cells in conjunction with assisting factor. Nature (1977) 1.32
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol (2000) 1.25
Splenic determination of immunocompetence: influence on other lymphoid organs. Cell Immunol (1971) 1.23
Adult murine lymph node cells respond blastogenically to a new differentiation antigen on isologous and autologous B lymphocytes. J Immunol (1975) 1.22
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. Urology (2000) 1.19
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials. Eur Urol (2000) 1.17
Mechanism of immunologic unresponsiveness: a new approach. Fed Proc (1990) 1.12
Immunoglobulin synthesis in hereditarily spleenless mice. Nature (1969) 1.12
Spontaneous delayed iso-hypersensitivity in guinea pigs. J Immunol (1968) 1.08
Immunologic responses of guinea pigs to dextran. J Immunol (1968) 1.07
Orally induced tolerance generates an efferently acting suppressor T cell and an acceptor T cell that together down-regulate contact sensitivity. J Immunol (1985) 1.06
Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides. Dig Dis Sci (1981) 1.03
Splenic replenishment of synergistic ability to bone marrow and thymic cells of neonatally splenectomized CBA mice. J Exp Med (1972) 0.97
Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function. Reg Immunol (1990) 0.97
Susceptibility to adjuvant arthritis in DA and F344 rats. A dominant trait controlled by an autosomal gene locus linked to the major histocompatibility complex. Arthritis Rheum (1982) 0.95
Specific immunologic unresponsiveness induced in adult guinea pigs with the aid of p-azobenzenearsonate hapten coupled to autologous red cells. J Immunol (1971) 0.93
Impaired delayed hypersensitivity in germ-free guinea-pigs. Immunology (1970) 0.90
Oral administration of the contact sensitizer trinitrochlorobenzene: initial sensitization and subsequent appearance of a suppressor population. Cell Immunol (1990) 0.90
Scandinavian clinical study of finasteride in the treatment of benign prostatic hyperplasia. Eur Urol (1992) 0.89
Proscar: five-year experience. Eur Urol (1995) 0.87
Specificity of fixation loci for homocytotropic antibodies. J Exp Med (1971) 0.87
Adoptive cutaneous anaphylaxis: a technique for studying antibody globulin synthesis. J Immunol (1966) 0.86
Suppression of adjuvant arthritis by antibodies specific for collagen type II. Immunol Commun (1981) 0.84
Use of immunotolerance to dissect the mechanisms regulating appearance of hapten-specific killer T cells in vivo. J Immunol (1980) 0.84
In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor. J Immunol (1983) 0.84
Imipenem/cilastatin: a multicentre international study of its clinical efficacy, safety and potential as empirical therapy. J Antimicrob Chemother (1986) 0.83
Down-regulation of adoptive adjuvant-induced arthritis by suppressor factor(s). Arthritis Rheum (1991) 0.81
Autologous and syngeneic mixed lymphocyte reactions and their immunological significance. Prog Allergy (1981) 0.81
Dissociation of HLA-D and HLA-DR using primed LD typing. Transplant Proc (1978) 0.81
Somatosensory evoked potentials predict neuromotor outcome after periventricular hemorrhage. Dev Med Child Neurol (1989) 0.80
Dextran augments delayed-type hypersensitivity by interrupting one limb of the suppressor cascade. J Immunol (1985) 0.79
Dextran abrogates stimulation of IgG antibody synthesis by allogeneic effect factor. J Immunol (1977) 0.79
Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources. Cancer Immunol Immunother (1990) 0.79
Effects of an antiserum to calf thymosin on lymphoid cells in vitro. Proc Soc Exp Biol Med (1969) 0.79
Human PL cells grown as continued T-cell cultures. Transplant Proc (1979) 0.79
In vitro lymphocyte transformation induced by pre-existing hypersensitivity to foetal calf serum. Clin Exp Immunol (1971) 0.79
Dextran's regulatory effect on immunoglobulin synthesis is mediated through T cells. Cell Immunol (1974) 0.78
The autologous mixed lymphocyte reaction is decreased in Freund's adjuvant-injected rats of arthritis-susceptible and -insusceptible strains. Arthritis Rheum (1985) 0.78
Dextran induces changes in immunological responses to unrelated antigenic and haptenic stimuli. Immunology (1973) 0.78
In vitro detection of spontaneously occurring delayed-type iso-hypersensitivity. Immunology (1971) 0.78
Occupational exposure to cholinesterase inhibiting pesticides: a Greek case. Int J Environ Health Res (2003) 0.78
Dextran-triggered T cells heighten T- and B-cell reactions to mitogens. Immunology (1976) 0.77
Tolerance to a defined chemical hapten produced in adult guinea-pigs after thymectomy. Immunology (1966) 0.77
Shared IgE-binding sites among separated components of natural rubber latex. Int Arch Allergy Immunol (1996) 0.77
Suppression of contact sensitivity and cell-mediated lympholysis by oral administration of hapten is caused by different mechanisms. Cell Immunol (1983) 0.77
T cell responses to select Ia determinants using the I-A mutant mouse strain B6.C-H-2bm12. J Immunol (1982) 0.77
Use of hapten-altered self moieties to probe the cell-mediated lympholytic response and immunotolerance interface. Immunol Rev (1980) 0.76
In the murine syngeneic mixed lymphocyte reaction, one T cell subset replicates in the presence of B cells or macrophages and replication is inhibited by simultaneous presence of both stimulator cells. Eur J Immunol (1986) 0.76
Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolism. Clin Endocrinol (Oxf) (1992) 0.76
Regulation of IgG antibody synthesis by a B cell component. Immunology (1977) 0.75
Characterization of dextran-activated T-cell factors. Immunology (1976) 0.75
Immunological unresponsiveness induced by non-phagocytosable immobilized hapten. Immunology (1971) 0.75
Capacity to interact with T-cell replacing factor correlates with acquisition by B cells of murine differentiation antigen-1. Immunology (1979) 0.75
Latex hypersensitivity: its prevalence among dental professionals. J Am Dent Assoc (1996) 0.75
Bee pseudocholinesterase as an indicator of exposure to anticholinesterase insecticides. Vet Hum Toxicol (1998) 0.75
Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections. Scand J Infect Dis Suppl (1987) 0.75
Isogeneic lymphocyte interactions (ILI) in CBA/N mice: presence of ILI-type 2 and absence of ILI-type 1. Cell Immunol (1981) 0.75
Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression. Cancer Immunol Immunother (1990) 0.75
External control of a shift in antibody synthesis. Adv Exp Med Biol (1976) 0.75
Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self. J Immunol (1984) 0.75
In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells. Eur J Immunol (1984) 0.75
DuB 15: a B-cell specificity in the HLA-D, -DR region. Transplant Proc (1978) 0.75
Allogeneic and autologous mixed lymphocyte reactions. Methods Enzymol (1987) 0.75
Immunological tolerance to self and non-self. Opening remarks and appreciation. Ann N Y Acad Sci (1982) 0.75
In vivo generation of hapten-specific killer T cells without elimination of suppressor cells. J Immunol (1979) 0.75
Isogeneic and allogeneic lymphocyte interactions may be controlled by cell surface immunoglobulin tropism. Cell Immunol (1976) 0.75
Interruption of tolerance toward a haptenic initiator of delayed-type hypersensitivity. J Immunol (1983) 0.75
Disturbance of oestrous cycles in rats following administration of Freund's complete adjuvant. J Reprod Fertil (1967) 0.75
Ongoing hapten-specific delayed-type hypersensitivity prevents generation of cytolytic T lymphocytes to the same hapten. Cell Immunol (1985) 0.75
In vivo regulation of the primary response of cytolytic T cells to hapten-altered self antigens by an inducible suppressor T cell. Ann N Y Acad Sci (1982) 0.75
A syngeneic splenic cell antigen induces a suppressor T cell in lymph nodes that controls cytotoxic T-cell and primary antibody responses. Cell Immunol (1987) 0.75
Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo. J Immunol (1983) 0.75
Bee head acetylcholinesterase as an indicator of exposure to organophosphate and carbamate insecticides. Vet Hum Toxicol (1996) 0.75
Peripheral tolerance induced in lymph nodes by syngeneic spleen cells inhibits generation of CTLs to hapten-altered self antigens but not to alloantigens. Cell Immunol (1991) 0.75
Natural cytotoxic T cells (NCTC) that differ from natural killer (NK) and natural cytotoxic (NC) cells are present in Peyer's patches of mice. Cell Immunol (1986) 0.75
Regulation of chemokine gene expression by contact hypersensitivity and by oral tolerance. Ann N Y Acad Sci (1996) 0.75
Suppressor T cells induced by epidermally applied hapten are located in bone marrow. Reg Immunol (1990) 0.75
A guinea pig model of hypersensitivity to allergenic fractions of natural rubber latex. Int Arch Allergy Immunol (1996) 0.75
Characterization of two suppressor cells that together prevent in vivo development of cytolytic T cells to hapten-altered self. Cell Immunol (1984) 0.75
Induced suppression of the efferent phase of contact sensitivity in rats. Cell Immunol (1990) 0.75
Novel alterations in sera from pseudopregnant and deciduoma-bearing rats. Nature (1967) 0.75
In vivo generation and regulation of killer T-cells directed towards hapten-coupled syngeneic cells. Ann N Y Acad Sci (1979) 0.75
The suppressor T cell induced by syngeneic splenic cell antigen down-regulates hapten-specific cytotoxic T cells by elaborating a factor inhibitory for IL2-dependent cell replication. Cell Immunol (1987) 0.75
Dextran alters induction of cell-mediated hypersensitivity. J Immunol (1978) 0.75
Specificity of primed LD typing: the major reactions. Transplant Proc (1979) 0.75
Correlation of B cell acquisition of differentiation antigens with capacity to interact with allogeneic effect factor (AEF). Adv Exp Med Biol (1979) 0.75
Generation of highly discriminant PLT cells using a hybrid HTC-PLT system. Transplant Proc (1977) 0.75
IgG recruiting component (GRC): B cell-derived signal for IgG antibody synthesis. J Immunol (1979) 0.75
Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors. J Immunol (1988) 0.75
Immunoregulatory aspects of in vivo syngeneic mixed lymphocyte reactions. Behring Inst Mitt (1983) 0.75